Patient familiarity with, understanding of, and preferences for clinical trial endpoints and terminology-Reference-Cited by-同舟云学术

Patient familiarity with, understanding of, and preferences for clinical trial endpoints and terminology

Published:2020-04-15 Issue:8 Volume:126 Page:1605-1613
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Itzstein Mitchell S.¹^ORCID,Railey Elda²^ORCID,Smith Mary L.²,White Carol B.²³,Sledge George W.²⁴,Howell John R.²⁵,Lawton Wendy²,Marinucci Donna M.²⁶,Unni Nisha¹⁷,Gerber David E.¹²⁷⁸^ORCID

Affiliation:

1. Department of Internal Medicine University of Texas Southwestern Medical Center Dallas Texas

2. Research Advocacy Network Plano Texas

3. CBWhite Evanston Illinois

4. Stanford University Medical Center Palo Alto California

5. Marriott School of Business Brigham Young University Provo Utah

6. College of Medicine Drexel University Philadelphia Pennsylvania

7. Harold C. Simmons Comprehensive Cancer Center University of Texas Southwestern Medical Center Dallas Texas

8. Department of Population and Data Sciences University of Texas Southwestern Medical Center Dallas Texas

Funder

National Cancer Institute

Genentech

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.32730

Reference48 articles.

1. Analysing data from patient-reported outcome and quality of life endpoints for cancer clinical trials: a start in setting international standards

3. Endpoints in cancer clinical trials

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes that matter to patients with cancer: living longer and living better;eClinicalMedicine;2024-10

2. Patient Understanding of Oncology Clinical Trial Endpoints in Direct-to-Consumer Television Advertising;The Oncologist;2023-04-20

3. Using qualitative interviews to identify patient-reported clinical trial endpoints and analyses that are the most meaningful to patients with advanced breast cancer;PLOS ONE;2023-01-17

4. Progression-free survival and quality of life in metastatic breast cancer: The patient perspective;The Breast;2022-10

5. Experts’ Views on FDA Regulatory Standards for Drug and High-Risk Medical Devices: Implications for Patient Care;Journal of General Internal Medicine;2022-02-09